ClinicalTrials.Veeva

Menu

CPAP Survival Study in Ghana

Columbia University logo

Columbia University

Status

Completed

Conditions

Acute Respiratory Infection
Pneumonia

Treatments

Device: CPAP

Study type

Interventional

Funder types

Other

Identifiers

NCT01839474
GENERAL ELECTRIC FOUNDATION (Other Grant/Funding Number)
AAAJ7954

Details and patient eligibility

About

The purpose of this study is to determine if the use of a continuous positive airway pressure (CPAP) machine (a device that blows air into the lungs) decreases the chance of a child dying from difficulty breathing.

Full description

Acute respiratory infections, malaria, and sepsis remain leading causes of death in children throughout the world.These conditions may lead to respiratory distress and eventually failure if not adequately managed. In developing countries with limited resources, advanced airway management and support can be challenging and needs to be approached in a different manner than is done in developed nations. For example, the use of invasive mechanical ventilation for respiratory distress is not an option in many resource-limited countries due to the lack of available technology, infrastructure, and trained personnel. Other alternatives should be utilized in order to support children with reversible conditions during their acute respiratory distress stage. One such alternative is non-invasive positive pressure.

Prior research demonstrated that nasal bubble CPAP can be successfully introduced and utilized in a developing country's emergency ward. Nurses in four Ghanaian district hospital emergency wards (Kintampo, Mampong,Nkoranza, and Wenchi) were able to safely apply CPAP and monitor the patient's response. The investigators demonstrated that patients receiving CPAP had a significant decrease in respiratory rate compared with those that did not with a mean difference of 14 breaths per minute. There were no major side effects associated with the use of CPAP. Now that CPAP has demonstrated to decrease respiratory rate in a non-specific disease population presenting with respiratory distress it is important to determine if it also improves survival. Therefore, the purpose of the study is to determine if the use of CPAP in children 1 month to 5 years of age with respiratory distress decreases mortality.

Enrollment

2,200 patients

Sex

All

Ages

1 month to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • One month to five years of age
  • Respiratory rate (RR) greater than 50 breaths per minute in three months to one year of age, and greater than 40 breaths per minute in one to five years of age
  • Presence of sub costal, intercostal, supraclavicular retractions or nasal flaring

Exclusion criteria

  • Age less than one month or older than five years
  • Skin breakdown around nose/mouth or facial trauma
  • Unable to protect airway
  • Uncontrollable emesis
  • Unresponsiveness
  • poor respiratory effort requiring positive pressure ventilation or invasive mechanical ventilation for respiratory failure
  • known or suspected pneumothorax

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,200 participants in 2 patient groups

CPAP
Experimental group
Description:
Children will be placed on nasal CPAP until they have an age appropriate respiratory rate and receive standard medical therapy.
Treatment:
Device: CPAP
Control
No Intervention group
Description:
Children will receive standard medical therapy.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems